Alzheimer's disease (AD) is the most common dementing disorder in the United States. AD already is a major public health burden that is poised to burgeon in the next generation. There is a clear therapeutic imperative for AD and a critical need to quickly and robustly validate candidate protectants from observational studies to insure that the best possible agents advance to randomized clinical trials, and to discover new and safe neuroprotectants. The long-term objective of this project is to provide pathological and biochemical validation of candidate protectants and to aid in the discovery of new candidates for AD. The Adult Changes in Thought (ACT) study is an ongoing large population-based longitudinal study involving approximately 3,200 elderly individuals who were cognitively intact when enrolled. A unique and powerful feature of ACT is its extensive pharmacy database that extends back to 1986. We propose to use this pharmacy database to test the hypothesis that some commonly used therapeutics suppress pathological features of AD-type neurodegeneration in elderly individuals without dementia, individuals with prodromal dementia, and patients with incident AD. We will test this hypothesis by determining associations between documented exposure to therapeutics and pathologic endpoints obtained in this project. Therapeutics to be evaluated include antihypertensives, antioxidants, non-steroidal anti-inflammatory drugs, hormone replacement therapy in women, and emerging candidate protectants identified during the course of this project. Pathologic endpoints to be determined in multiple brain regions obtained by rapid autopsy protocol are: (1) magnitude of oxidative damage to neuronal membranes (2) dendritic and synaptic degeneration (3) protein insolubility (4) density and staging of histopathologic structures, viz., neuritic plaques, neurofibrillary tangles, and Lewy bodies. This study offers a unique opportunity to discover and validate candidate protectants from among commonly used therapeutics, an endeavor unlikely to be pursued by pharmaceutical industry, and will provide needed rational either for or against the advancement of candidate protectants in randomized clinical trials for prevention of AD. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG023801-03
Application #
7258973
Study Section
Clinical Neuroscience and Disease Study Section (CND)
Program Officer
Anderson, Dallas
Project Start
2005-08-01
Project End
2010-07-31
Budget Start
2007-08-01
Budget End
2008-07-31
Support Year
3
Fiscal Year
2007
Total Cost
$285,340
Indirect Cost
Name
University of Washington
Department
Pathology
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Dublin, Sascha; Anderson, Melissa L; Heckbert, Susan R et al. (2014) Neuropathologic changes associated with atrial fibrillation in a population-based autopsy cohort. J Gerontol A Biol Sci Med Sci 69:609-15
Montine, Thomas J; Sonnen, Joshua A; Montine, Kathleen S et al. (2012) Adult Changes in Thought study: dementia is an individually varying convergent syndrome with prevalent clinically silent diseases that may be modified by some commonly used therapeutics. Curr Alzheimer Res 9:718-23
Postupna, Nadia; Rose, Shannon E; Bird, Thomas D et al. (2012) Novel antibody capture assay for paraffin-embedded tissue detects wide-ranging amyloid beta and paired helical filament-tau accumulation in cognitively normal older adults. Brain Pathol 22:472-84
Back, Stephen A; Kroenke, Christopher D; Sherman, Larry S et al. (2011) White matter lesions defined by diffusion tensor imaging in older adults. Ann Neurol 70:465-76
Sonnen, Joshua A; Santa Cruz, Karen; Hemmy, Laura S et al. (2011) Ecology of the aging human brain. Arch Neurol 68:1049-56
Naj, Adam C; Jun, Gyungah; Beecham, Gary W et al. (2011) Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet 43:436-41
SantaCruz, Karen S; Sonnen, Joshua A; Pezhouh, Maryam Kherad et al. (2011) Alzheimer disease pathology in subjects without dementia in 2 studies of aging: the Nun Study and the Adult Changes in Thought Study. J Neuropathol Exp Neurol 70:832-40
Tsuang, Debby; Larson, Eric B; Li, Ge et al. (2010) Association between lifetime cigarette smoking and lewy body accumulation. Brain Pathol 20:412-8
Sonnen, J A; Larson, E B; Walker, R L et al. (2010) Nonsteroidal anti-inflammatory drugs are associated with increased neuritic plaques. Neurology 75:1203-10
Sonnen, Joshua A; Postupna, Nadia; Larson, Eric B et al. (2010) Pathologic correlates of dementia in individuals with Lewy body disease. Brain Pathol 20:654-9

Showing the most recent 10 out of 26 publications